Evaluating Patient-Reported Outcomes in Cushing’s Syndrome

• Namrata Gumaste ^[3] ; Leena Shah ^[1] ; Khadeen Christi Cheesman ^[1] ; Eliza B. Geer ^[2]
  1. [1] Icahn School of Medicine at Mount Sinai

     Icahn School of Medicine at Mount Sinai

     Estados Unidos

     
  2. [2] Memorial Sloan Kettering Cancer Center

     Memorial Sloan Kettering Cancer Center

     Estados Unidos

     
  3. [3] Department of Medicine, Weill Cornell Medicine, New York-Presbyterian Hospital, 505 East 70th Street, Suite 450, New York, NY 10021, USA

  Mostrar afiliaciones +
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 51, Nº. 4, 2022, págs. 691-707
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The importance of the patient's perspective on disease has increasingly gained traction among clinical investigators and clinicians. Patient-reported outcomes (PROs) are those which pertain to a patient's health, quality of life, or functional status (associated with health care or treatment) that are reported directly by the patient, without interpretation by a clinician. In this article, we will review PROs as they relate to the signs, symptoms, health-related quality of life, and comorbidities of active Cushing's syndrome (CS), and CS after treatment with surgery, radiotherapy, and medical therapy. We will explore long-term outcomes in the setting of remission, persistence, and recurrence in this population.